Generic Name: lanreotide

This medication has been identified as Somatuline Depot 60 mg/0.2 mL prefilled syringe. It is supplied by Ipsen Biopharmaceuticals, Inc.

Somatuline Depot is used in the treatment of Neuroendocrine Carcinoma; Carcinoid Syndrome; Acromegaly and belongs to the drug class somatostatin and somatostatin analogs. Risk cannot be ruled out during pregnancy. Somatuline Depot 60 mg/0.2 mL prefilled syringe is not a controlled substance under the Controlled Substances Act (CSA).